Abstract: INFO13-FR
The Inherited and Polycystic Kidney Disease Program at Children's National Hospital
Session Information
- Informational Posters - 2
October 23, 2026 | Location: Exhibit Hall A, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Pediatric Nephrology
- No subcategory defined
Authors
- Wink, Krista Renee, Children's National Hospital, Washington, District of Columbia, United States
- Salcedo-Giraldo, Jordy, Children's National Hospital, Washington, District of Columbia, United States
- Freiman, Andrew, Children's National Hospital, Washington, District of Columbia, United States
- Dadzie, Nicholas, Children's National Research & Innovation Campus, Washington, District of Columbia, United States
- Pyle, Louise C., Children's National Hospital, Washington, District of Columbia, United States
- Ward, Stephanie Catherine, Children's National Hospital, Washington, District of Columbia, United States
- Vogel, Siobhan, Children's National Hospital, Washington, District of Columbia, United States
- Gulati, Ashima, Children's National Hospital, Washington, District of Columbia, United States
Group or Team Name
- IPKD Program Team
Description
The Inherited & Polycystic Kidney Disease (IPKD) Program at Children's National Hospital in Washington, DC, is a multidisciplinary nephrogenetics program for children with kidney diseases of known or suspected genetic etiology. This pediatric kidney genetics program offers personalized multidisciplinary care by integrating our core services in nephrology with genetic, hepatic, nutrition, and psychosocial services and provides guided referrals to specialized programs.
We encourage informed participation in research, including:
1) The Genetic Studies of Heritable Kidney Diseases Registry that assesses genotype-phenotype correlations to define clinical outcomes and reclassify variants of uncertain significance in patients with renal disease.
2) An active industry-sponsored phase 3b clinical trial for children (NCT04782258) diagnosed with ARPKD.
3) The PKD Foundation ADPKD Registry (NCT04039061) for patients with ADPKD.
4) Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource (CHOP, NCT01401998), led by Dr. Lisa Guay-Woodford, that documents the genetic and clinical characteristics of ARPKD and related conditions.
Children's National hosts several core research facilities, notably:
1) The Center for Precision Medicine and Genomics Research that encourages collaboration between its interdisciplinary faculty to discover new multisystemic interactions and treatments for rare disorders.
2) The Laboratory and Pathology Research Core that hosts a Pediatric Biorepository to facilitate the storage of pediatric biospecimens for research use.